A scientific review evaluates how herbal phytochemicals mitigate drug-induced kidney toxicity in preclinical studies while ...

A review in Molecular Cancer examines how antibody-drug conjugates treat solid tumors while addressing clinical resistance, ...

For pharmacists, physicians, and nurses handling anti-MRSA drugs in the ICU, we have summarized the key points for vancomycin ...

InflaRx announced the publication of Phase 1 clinical trial results for Izicopan, an experimental oral treatment being developed for inflammatory and immune-related diseases. The ...

Izicopan achieved rapid and sustained inhibition of C5a/C5aR1 signalingPharmacokinetic results demonstrated dose-dependent exposure, with ...

Evommune licensed a drug that erases an immune protein to bypass JAK inhibitor warnings; Caldera added a TL1A bispecific from ...

Mondego Bio doses first humans with oral MB-388, an immunotherapy-resistance drug targeting the PTPN2/PTPN1 pathway. Phase 1a ...

Cork startup ArrayPatch builds dissolving microneedles entirely from the drug itself — no polymer — and may put GLP-1 obesity ...

SALT LAKE CITY, Nov. 5, 2026 /PRNewswire/ -- (NASDAQ: LPCN), a specialty pharmaceutical company focused on the development of ...

CANTANHEDE, Portugal, Nov 5, 2026 – Portuguese biotechnology company Mondego Bio has initiated its first human clinical trial ...

In preclinical studies, FT2109 showed a differentiated profile, including high potency and oral bioavailability, anti-inflammatory activity comparable to biologic TNF inhibition in preclinical disease ...

Acepodia (6976: TT), a clinical-stage biotechnology company developing next-generation cell therapies and antibody-drug ...